Tab. II.

General trend of notifications made in the period 2011-2022 and statistical evaluation between the pandemic period (2020-2022) and the pre-pandemic one (2011-2019).

	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	Spearman’s test
Acute hepatitis B	3	1	2	2	0	2	2	4	0	0	1	1	ns
Brucellosis	16	11	32	17	13	137	11	6	7	5	4	2	p = 0.0046
Hepatitis A	6	3	2	0	1	0	22	3	2	1	0	0	ns
Legionellosis	0	1	0	2	0	0	1	5	7	3	2	4	ns
Measles	31	1	0	0	1	0	63	33	1	0	0	0	ns
Meningoencephalitis	7	8	14	12	20	15	12	9	4	3	2	2	p = 0.0045
Mumps	3	6	0	0	1	3	2	5	2	0	2	1	ns
Non-tuberculous mycobacteriosis	3	2	2	1	1	0	0	5	4	5	6	1	ns
Non-typhoid salmonellosis	7	12	8	3	3	8	4	15	7	13	8	4	ns
Pediculosis	0	25	30	63	0	0	0	5	0	0	2	1	ns
Pertussis	7	2	3	2	6	2	3	2	4	0	0	0	p = 0.0032
Rickettsiosis	8	14	8	3	8	5	6	2	2	1	0	2	p = 0.0102
Rubella	1	11	0	0	0	0	1	0	0	0	0	0	ns
Scabies	0	15	21	8	17	0	0	46	33	52	68	85	p = 0.0043
Scarlet fever	30	7	11	0	2	36	15	5	4	2	0	0	p = 0.0320
Syphilis	9	4	6	2	7	10	4	9	4	10	3	9	ns
Tetanus	0	0	1	0	1	0	1	1	1	0	0	0	ns
Tuberculosis	38	27	23	16	24	29	29	27	19	17	20	6	p = 0.0446
Varicella	29	33	110	51	23	38	129	32	40	11	4	1	p = 0.0047
Other	27	26	13	38	2	32	26	11	20	12	8	9	ns
TOTAL	225	209	286	220	130	317	331	225	161	135	130	128	p = 0.0282
ns: not significant.